THS 2.2
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for THS 2.2, covering 2016-10-13 to 2020-12-04. Get the full timeline:
Most recent: Clinical Trial Update: A 26-week Extension of the ZRHR-ERS-09-US Study Evaluating Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2 [NA]